APS Sharon S. Keller Chronic Pain Research Grant
This new grants program has been established to fund research projects that have a high likelihood of leading to new treatments, increased access to/and or expansion of treatment options for people with chronic pain.
APS Future Leaders in Pain Research Grants Program
The Future Leaders in Pain Research Grants Program has been established to fund research projects of doctorally-prepared investigators who have not yet attained NIH RO1 level funding.
Rita Allen Foundation Award in Pain
The American Pain Society and Rita Allen Foundation have announced a call for applications for the Rita Allen Foundation Award in Pain. The RAF and APS may award two grants in the amount of $50,000 annually, for a period of up to three years to those research proposals demonstrating the greatest merit and potential for success.
Pfizer Announces the ASPIRE 2014 Neuropathic Pain Program
The mission of the ASPIRE 2014 Neuropathic Pain Program is to support novel research through a competitive grant program that advances medical and scientific knowledge in neuropathic pain. This program underscores Pfizer’s longstanding and ongoing commitment to the research and treatment of pain by supporting investigators with an interest in advancing their research in this area.
The ASPIRE 2014 Neuropathic Pain Program is focused on developing knowledge within this disease state through supporting novel research in the exploration of key endpoints, novel neuropathic pain models and in neuroimaging of neuropathic pain. This program is open to investigators within the United States. Winning research proposals will be selected by an independent, external expert review panel. Pfizer is funding up to three two-year awards ranging from $50,000 to a maximum of $150,000 each.
Please visit the ASPIRE website for Research Requirements and for additional guidance.
Key Dates
Application deadline: Wednesday July 9, 2014 (by 11:59pm EST).
Notification of awards recipients and award acceptance: August 2014
Award expected to start by: December 2014
Completion of award: Research must be completed within two years of start date
Notice of Grant Opportunity in Chronic Pain
Pfizer recently opened an RFP in the area of “Employing Integrated and Coordinated Multimodal-Therapies in a Primary Care Setting to Improve Outcomes and Optimize Healthcare Utilization for Patients with Chronic Pain.” Information about this may be found at http://www.pfizer.com/files/RFPImprovingChronicPainOutcomes6.17.14.pdf. Please make note that the first deadline is July 17th, when a letter of intent is due.
Howard Hughes Medical Institute Announces $150 Million Investigators Competition
The Howard Hughes Medical Institute has announced that it hopes to identify a new cohort of as many as twenty-five biomedical researchers through a national open competition. The initiative represents an investment of approximately $150 million over the next five years. The HHMI Investigator competition will be open to basic researchers and physician scientists who hold a tenured or tenure-track position in biology or biomedical disciplines—including plant biology, evolutionary biology, chemical biology, biomedical engineering, and computational biology—at any one of more than two hundred eligible institutions. Selected researchers will receive a five-year appointment as an HHMI investigator that will be renewable pending review.
International Association for the Study of Pain (IASP) Program of Grants and Awards
IASP has an extensive grants and awards program to support investigators working in basic or clinical research and to support education in developing countries. Visit the IASP Grants and Awards section of the IASP website for a list of available grants and awards.
Mallinckrodt Foundation Grant Program
The Edward Mallinckrodt, Jr. Foundation is a private foundation that funds basic biomedical research in St Louis and throughout the United States. The mission of the Foundation is to support early stage investigators engaged in biomedical research that has the potential to significantly advance the understanding, diagnosis, or treatment of disease.